{"title":"Association between bone mineral density T-score and respiratory sarcopenia in older adults.","authors":"Ying Liu, Yutong Guo, Shun Xie, Yunyuan Kong, Jixiong Xu","doi":"10.3389/fmed.2025.1534208","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Respiratory sarcopenia, characterized by reduced respiratory muscle mass and strength, is underdiagnosed in older adults. This cross-sectional study aimed to investigate the association between bone mineral density (BMD) T-score and respiratory sarcopenia in a Chinese population.</p><p><strong>Methods: </strong>A total of 530 participants aged ≥60 years were recruited. Respiratory sarcopenia was diagnosed based on peak expiratory flow rate (PEFR) cutoffs. BMD was measured using dual-energy X-ray absorptiometry, and muscle mass was assessed using bioelectrical impedance analysis. Logistic regression models were used to analyze the association between BMD T-score and respiratory sarcopenia risk.</p><p><strong>Results: </strong>Participants with respiratory sarcopenia exhibited lower BMD T-score, appendicular skeletal muscle index, trunk muscle mass ratio, and lung function parameters compared to those without respiratory sarcopenia. The odds ratio (95% CI) for the lowest BMD T-score tertile with the risk of respiratory sarcopenia was 4.52 (1.71-13.1) compared with the highest tertile. This association remained significant after adjusting for confounding factors.</p><p><strong>Conclusion: </strong>BMD T-score is significantly associated with an increased risk of respiratory sarcopenia in older adults. This finding highlights the importance of bone mass monitoring and early prevention strategies to reduce the incidence of respiratory sarcopenia.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1534208"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11915466/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1534208","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Respiratory sarcopenia, characterized by reduced respiratory muscle mass and strength, is underdiagnosed in older adults. This cross-sectional study aimed to investigate the association between bone mineral density (BMD) T-score and respiratory sarcopenia in a Chinese population.
Methods: A total of 530 participants aged ≥60 years were recruited. Respiratory sarcopenia was diagnosed based on peak expiratory flow rate (PEFR) cutoffs. BMD was measured using dual-energy X-ray absorptiometry, and muscle mass was assessed using bioelectrical impedance analysis. Logistic regression models were used to analyze the association between BMD T-score and respiratory sarcopenia risk.
Results: Participants with respiratory sarcopenia exhibited lower BMD T-score, appendicular skeletal muscle index, trunk muscle mass ratio, and lung function parameters compared to those without respiratory sarcopenia. The odds ratio (95% CI) for the lowest BMD T-score tertile with the risk of respiratory sarcopenia was 4.52 (1.71-13.1) compared with the highest tertile. This association remained significant after adjusting for confounding factors.
Conclusion: BMD T-score is significantly associated with an increased risk of respiratory sarcopenia in older adults. This finding highlights the importance of bone mass monitoring and early prevention strategies to reduce the incidence of respiratory sarcopenia.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world